Epigenica
3 known investors
Epigenica develops products for epigenetic analysis, including its EpiFinder platform, a multiplexed ChIP-seq technology built on patented hmqChIP-seq for high-throughput profiling of epigenetic marks such as DNA methylation and histone modifications. Its tools target researchers studying epigenetic biomarkers to support human health research.